CTI-BIOTECH  est membre de Lyonbiopôle

General information

5 avenue Lionel Terray

69330 Meyzieu

Incorporated in: 2008/12/11

Number of employees: 5

Turnover: €650K (in 2014)


Main activity

CTI-BIOTECH studies adult and neonatal stem cell populations to investigate biological systems regulating cell proliferation and differentiation into endodermal, mesodermal and ectodermal lineages. CTI-BIOTECH developed and validated a range of technologies enabling 2D and 3-dimensional tissue engineering using bioreactors, biomaterials and clinical-grade growth factors. CTI-BIOTECH’s research applications include bioassay development, drug screening platforms, biomedical device, cGMPbioprocessing and clinical applications. CTI-BIOTECH runs pre-clinical and clinical programmes to enable cell therapy applications for diabetes, stroke, cerebral palsy, hemato- immunological diseases, cranio-facial malformations, orthopaedic lesions, cancer. CTI-BIOTECH develops 3D bioassays for molecular screening and toxicology platforms from human stem cells.


Nature of funding searches: Contact office@ctibiotech.com


Strategic area of application
Human Medicine

Application market
Dermatology & Cosmetology - Immune, AutoIm & Inflam. diseases - Oncology

Therapeutics, Pharma or Biotech - Medical device

Analytical & Diagnostic services - Cell Therapy - cell biology - Biobanking - Regenerative medicine

En poursuivant votre navigation sur ce site, vous acceptez l'utilisation de cookies pour vous proposer des services et offres adaptés à vos centres d'intérêt. En savoir plus... Fermer